RPRD partners with St. Jude Children’s Hospital to offer pharmacogenetics testing
RPRD Diagnostics, a privately-held, Wisconsin-based precision medicine company, announced a collaboration with St. Jude Children’s Research Hospital. RPRD Diagnostics will perform preemptive, comprehensive clinical pharmacogenetics testing for St. Jude’s PG4KDS program. October 19, 2017